Methotrexate (Ingredient)
Chemical formula: C20H22N8O5
Drugbank ID: DB00563
ATC codes: L04AX03, L01BA01
The information below refers to products available in the United States that contain methotrexate.
Products containing methotrexate
methotrexate systemic
Brand names: Methotrexate LPF Sodium, Trexall, Otrexup, Rasuvo, Rheumatrex Dose Pack
Drug classes: antimetabolites, antipsoriatics, antirheumatics, other immunosuppressants
Methotrexate systemic is used in the treatment of:
- Acute Lymphoblastic Leukemia
- Acute Lymphocytic Leukemia
- Acute Nonlymphocytic Leukemia
- Bladder Cancer
- Brain Tumor
- Breast Cancer
- Bullous Pemphigoid
- Cervical Cancer
- Choriocarcinoma
- Cogan's Syndrome
- Colorectal Cancer
- Dermatomyositis
- Ectopic Pregnancy
- Eczema
- Esophageal Carcinoma
- Gastric Cancer
- Graft-versus-host disease
- Head and Neck Cancer
- Hodgkin's Lymphoma
- Lymphoma
- Mantle Cell Lymphoma
- Meningeal Leukemia
- Mycosis Fungoides
- Neoplastic Diseases
- Non Small Cell Lung Cancer
- Non-Hodgkin's Lymphoma
- Osteosarcoma
- Ovarian Cancer
- Pancreatic Cancer
- Pemphigoid
- Pemphigus
- Pityriasis rubra pilaris
- Polyarticular Juvenile Idiopathic Arthritis
- Psoriasis
- Psoriatic Arthritis
- Rheumatoid Arthritis
- Scleroderma
- Small Cell Lung Cancer
- Soft Tissue Sarcoma
- Solid Tumors
- Systemic Sclerosis
- Trophoblastic Disease
- Uveitis
Chemical structure
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
